Literature DB >> 7626790

Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier.

R Hallmann1, D N Mayer, E L Berg, R Broermann, E C Butcher.   

Abstract

Few markers specific for mouse endothelium exist. We describe here one such marker, MECA-32, a monoclonal antibody which shows high specificity for mouse endothelium in both embryonic and mature tissues. The MECA-32 antigen has a M(r) of 50-55 x 10(3) under reducing conditions and M(r) of 100-120 x 10(3) under nonreducing conditions. It is expressed on most endothelial cells in the embryonic and in the adult mouse, with the exception of the brain, skeletal, and cardiac muscle, where it has a more restricted distribution. In skeletal and cardiac muscle only small arterioles and venules express the MECA-32 antigen, while in the brain its expression is negatively correlated with the differentiation of the vasculature to form the blood brain barrier. Interestingly, during embryonic development the antigen occurs on the brain vasculature up to day 16 of gestation (E16), whereupon it disappears. The embryonic brain is an avascular organ anlage which is vascularized by ingrowth of external blood vessels. Differentiation of the vasculature to form the blood brain barrier occurs at approximately E16 in the mouse. This differentiation correlates with the downregulation of MECA-32 antigen expression. Between E12 and E16 MECA-32 detects most endothelial cell surfaces of the blood vessels in the brain. No MECA-32 antigen is found in the brain at E17 or any later stage of development with the exception of the vasculature of the circumventricular organs. The results suggest that MECA-32 antigen expression is temporally and spatially correlated with the development of the blood brain barrier.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626790     DOI: 10.1002/aja.1002020402

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  75 in total

Review 1.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

2.  Platelets are relevant mediators of renal injury induced by primary endothelial lesions.

Authors:  Claudia Schwarzenberger; Jan Sradnick; Kenneth M Lerea; Michael S Goligorsky; Bernhard Nieswandt; Christian P M Hugo; Bernd Hohenstein
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-01

Review 3.  The inner blood-retinal barrier: Cellular basis and development.

Authors:  Mónica Díaz-Coránguez; Carla Ramos; David A Antonetti
Journal:  Vision Res       Date:  2017-06-27       Impact factor: 1.886

4.  Reck enables cerebrovascular development by promoting canonical Wnt signaling.

Authors:  Florian Ulrich; Jorge Carretero-Ortega; Javier Menéndez; Carlos Narvaez; Belinda Sun; Eva Lancaster; Valerie Pershad; Sean Trzaska; Evelyn Véliz; Makoto Kamei; Andrew Prendergast; Kameha R Kidd; Kenna M Shaw; Daniel A Castranova; Van N Pham; Brigid D Lo; Benjamin L Martin; David W Raible; Brant M Weinstein; Jesús Torres-Vázquez
Journal:  Development       Date:  2015-12-10       Impact factor: 6.868

5.  Absence of the alpha v beta 3 integrin dictates the time-course of angiogenesis in the hypoxic central nervous system: accelerated endothelial proliferation correlates with compensatory increases in alpha 5 beta 1 integrin expression.

Authors:  Longxuan Li; Jennifer V Welser; Richard Milner
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

Review 6.  The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.

Authors:  Britta Engelhardt; Lydia Sorokin
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

7.  Microglial activation in the hippocampus of hypercholesterolemic rabbits occurs independent of increased amyloid production.

Authors:  Qing-Shan Xue; D Larry Sparks; Wolfgang J Streit
Journal:  J Neuroinflammation       Date:  2007-08-24       Impact factor: 8.322

8.  An In Vivo Blood-brain Barrier Permeability Assay in Mice Using Fluorescently Labeled Tracers.

Authors:  Kavi Devraj; Sylvaine Guérit; Jakranka Macas; Yvonne Reiss
Journal:  J Vis Exp       Date:  2018-02-26       Impact factor: 1.355

9.  Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Authors:  Shanna A Arnold; Lee B Rivera; Andrew F Miller; Juliet G Carbon; Sean P Dineen; Yang Xie; Diego H Castrillon; E Helene Sage; Pauli Puolakkainen; Amy D Bradshaw; Rolf A Brekken
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

10.  Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.

Authors:  Miao Wang; Mary Topalovski; Jason E Toombs; Christopher M Wright; Zachary R Moore; David A Boothman; Hiromi Yanagisawa; Huamin Wang; Agnieszka Witkiewicz; Diego H Castrillon; Rolf A Brekken
Journal:  Cancer Res       Date:  2015-11-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.